Health-care companies rose as traders rotated back into a sector that had fallen out of favor. Shares of insurers such as Humana and UnitedHealth Group added to recent gains following weak performance ...

Add Sam's Club to the list of retail pharmacy options for consumers who want to buy the pricey weight-loss drugs Ozempic and Wegovy. Sam's Club pharmacies now sell Novo Nordisk's Wegovy and Ozempic ...

Moderately bullish activity in Novo Nordisk (NVO), with shares up 68c, or 1.16%, near $59.70. Options volume relatively light with 42k contracts traded and calls leading puts for a put/call ratio of 0 ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Costco members with a valid prescription can pay the $499 self-pay price and insurance coverage will vary by plan for a 4-week supply of Ozempic or Wegovy. HealthDay News — Costco shoppers will be ...

Hims & Hers HealthHIMS is Wednesday's IBD Stock Of The Day. After returning to the IBD 50, Hims stock is making a second attempt at a breakout since late July.The telehealth giant announced its ...

A medical expert has made a case for taking smaller GLP-1 injections, despite manufacturers warning against the practice.

Novo Nordisk, the company that owns both Wegovy and Ozempic, will be selling the medicine at nearly half the out-of-pocket price of other pharmacies at just $499. The company’s U.S. president David ...

The company, Novo Nordisk, said Friday that prescription-only injectable pens for both drugs will be sold at more than 500 Costco pharmacies in the United States. Executive members and people with ...

Shares of Costco (NASDAQ:COST) have finally entered correction territory, dipping by close to 14% from its all-time highs. Indeed, buying the dip in the beloved bulk-buy retailer has paid off in a big ...

Costco, which has eight CT stores, has signed a deal with Novo Nordisk to sell Wegovy and Ozempic injections at $499 per month.

A federal appeals court unanimously rejected a Novo Nordisk challenge to Medicare’s drug price negotiation program, a ruling that will allow the government to lump together products with the same ...